GlassScriptPhysician profile
Robert M Esposito
NPI 1649310541
$573.24
in general payments reported to CMS, 2019-2025
12 companies · $35.63 in 2025
The $35.63 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.77 · 2020: $167 · 2021: $111 · 2022: $45.38 · 2023: $118 · 2024: $64.68 · 2025: $35.63.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.00 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Access Systems, INC. | $148.57 | 2020-2021 | |
| Csl Behring | $57.88 | 2019-2024 | Kcentra |
| Janssen Pharmaceuticals, INC | $53.62 | 2020-2023 | Xarelto |
| Pfizer INC. | $49.04 | 2021-2025 | |
| Allergan, INC. | $47.26 | 2019-2020 | |
| Abbvie INC. | $44.95 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $44.68 | 2024 | Imfinzi |
| Inari Medical, INC. | $42.03 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Si-Bone, INC. | $35.38 | 2023 | |
| Alexion Pharmaceuticals, INC. | $17.85 | 2021 | |
| Purdue Pharma L.P. | $16.59 | 2025 | Nalmefene Hydrochloride |
| Portola Pharmaceuticals, LLC | $15.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Esposito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.